{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:27:22Z","timestamp":1772252842566,"version":"3.50.1"},"reference-count":30,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sanofi Germany"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Functional gastrointestinal disorders (FGIDs), including irritable bowel syndrome (IBS), are frequently handled by self-management with over-the-counter (OTC) products such as hyoscine butylbromide (HBB), alone or in combination with paracetamol, and natural products such as peppermint oil. To obtain real-world information, we have performed an anonymous pharmacy-based patient survey among 1686 users of HBB, HBB + paracetamol, and peppermint oil. Based on the distinct but overlapping indications for the three OTC products, multiple logistic regression was applied to compare them in users reporting gastrointestinal cramps and pain, bloating, flatulence, or IBS as cardinal symptoms. All three treatments reduced symptoms and associated impairments of work\/daily chores, leisure activities, and sleep by approximately 50%. Based on the four cardinal symptoms and the four dependent continuous variables of interest (change in intensity of symptoms and of the three impairment domains) a total of 16 logistic regression models were applied. HBB, HBB + paracetamol, and peppermint oil had similar reported overall effectiveness in those models. Gender, age, baseline symptom severity, and impairment in one of three domains had small and inconsistent effects on perceived treatment success. We provide evidence that HBB, HBB + paracetamol, and peppermint oil have comparable effectiveness in their approved indications under real-world conditions in an OTC setting.<\/jats:p>","DOI":"10.3390\/jcm11216361","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T07:26:50Z","timestamp":1667114810000},"page":"6361","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Self-Medication for the Treatment of Abdominal Cramps and Pain\u2014A Real-Life Comparison of Three Frequently Used Preparations"],"prefix":"10.3390","volume":"11","author":[{"given":"Martin","family":"Storr","sequence":"first","affiliation":[{"name":"Center of Endoscopy, 82319 Starnberg, Germany"},{"name":"Medical Clinic II, Ludwig-Maximilians-University, 81377 Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Weigmann","sequence":"additional","affiliation":[{"name":"Consumer Health Care, Sanofi Germany, 65926 Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1162-9851","authenticated-orcid":false,"given":"Sabine","family":"Landes","sequence":"additional","affiliation":[{"name":"Consumer Health Care, Sanofi Germany, 65926 Frankfurt, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4161-8467","authenticated-orcid":false,"given":"Martin C.","family":"Michel","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University Medical Center, Johannes Gutenberg University, 55131 Mainz, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1023\/A:1005554103531","article-title":"Abdominal pain, bloating, and diarrhea in the United States: Prevalence and impact","volume":"45","author":"Sandler","year":"2000","journal-title":"Dig. Dis. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0399-8320(04)95011-7","article-title":"Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria","volume":"28","author":"Bommelaer","year":"2004","journal-title":"Gastroenterol. Clin. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2016.02.014","article-title":"Development and validation of the Rome IV diagnostic questionnaire for adults","volume":"150","author":"Palsson","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5223\/pghn.2017.20.1.1","article-title":"The new Rome IV criteria for functional gastrointestinal disorders in infants and toddlers","volume":"20","author":"Zeevenhooven","year":"2017","journal-title":"Pediatr. Gastroenterol. Hepatol. Nutr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2036.2010.04368.x","article-title":"Drug treatment of chronic-intermittent abdominal cramping and pain: A multi-national survey on usage and attitudes","volume":"32","author":"Quigley","year":"2010","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2165\/00003495-200767090-00007","article-title":"Hyoscine butylbromide: A review of its use in the treatment of abdominal cramping and pain","volume":"67","author":"Tytgat","year":"2007","journal-title":"Drugs"},{"key":"ref_8","unstructured":"European Medicines Agency (2022, August 15). Assessment Report on Mentha x piperita L., folium and Aetheroleum. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/herbal-monograph\/european-union-herbal-monograph-mentha-x-piperita-l-folium-revision-1_en.pdf."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1111\/j.1365-2036.2006.02818.x","article-title":"Placebo- and paracetamol-controlled study on the efficacy and tolerability of hyoscine butylbromide in the treatment of patients with recurrent crampy abdominal pain","volume":"23","author":"Tytgat","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4236\/pp.2011.22010","article-title":"Symptoms and their interpretation in patients self-treating abdominal cramping and pain with a spasmolytic (butylscoplolamine bromide)\u2014A pharmacy-based survey","volume":"2","author":"Kondla","year":"2011","journal-title":"Pharmacol. Pharm."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1186\/s40064-016-2369-0","article-title":"Results from a pharmacy-based patient survey on the use of a fixed combination analgesic containing acetylsalicylic acid, paracetamol and caffeine by self-diagnosing and self-treating patients","volume":"5","author":"Gaul","year":"2016","journal-title":"Springerplus"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e12907","DOI":"10.1111\/ijcp.12907","article-title":"Factors associated with efficacy of an ibuprofen\/pseudoephedrine combination drug in pharmacy customers with common cold symptoms","volume":"71","author":"Klimek","year":"2017","journal-title":"Int. J. Clin. Pract."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kardos, P., Beeh, K.-M., Sent, U., Mueck, T., Gr\u00e4ter, H., and Michel, M.C. (2018). Characterization of differential patient profiles and therapeutic responses of pharmacy customers for four ambroxol formulations. BMC Pharmacol. Toxicol., 19.","DOI":"10.1186\/s40360-018-0229-y"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"902020","DOI":"10.3389\/fneur.2022.902020","article-title":"Impact of the neck and\/or shoulder pain on self-reported headache treatment responses\u2014Results from a pharmacy-based patient survey","volume":"13","author":"Gaul","year":"2022","journal-title":"Front. Neurol."},{"key":"ref_15","first-page":"e100046","article-title":"Systematic review of guidelines for internal validity in the design, conduct and analysis of preclinical biomedical experiments involving laboratory animals","volume":"4","author":"Vollert","year":"2020","journal-title":"BMJ Open Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1124\/dmd.119.090027","article-title":"New author guidelines for displaying data and reporting data analysis and statistical methods in experimental biology","volume":"48","author":"Michel","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/d41586-019-00857-9","article-title":"Scientists rise up against statistical significance","volume":"567","author":"Amrhein","year":"2019","journal-title":"Nature"},{"key":"ref_18","first-page":"46","article-title":"A multi-centre, double-blind evaluation against placebo of the therapeutic effect of hyoscine-N-butylbromide in patients with abdominal pain","volume":"1","author":"Miyoshi","year":"1976","journal-title":"Pharmatherapeutica"},{"key":"ref_19","first-page":"436","article-title":"Antalgic properties of proxazole. Double blind study in visceral algoplastic conditions","volume":"11","author":"Damiani","year":"1969","journal-title":"Panminerva Med."},{"key":"ref_20","first-page":"1237","article-title":"Treatment of functional abdominal distress. Double-blind test with Buscopan and Tranquo-Buscopan","volume":"100","author":"Neiger","year":"1970","journal-title":"Schweiz Med. Wochenschr."},{"key":"ref_21","first-page":"488","article-title":"The treatment of irritable colon. Efficacy and tolerance of buscopan plus, buscopan, paracetamol and placebo in ambulatory patients with irritable colon","volume":"108","author":"Ewe","year":"1990","journal-title":"Fortschr. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.1.6160.376","article-title":"Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk","volume":"1","author":"Ritchie","year":"1979","journal-title":"Br. Med. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.5414\/CP201485","article-title":"Efficacy and tolerability of two oral hyoscine butylbromide formulations in Chinese patients with recurrent episodes of self-reported gastric or intestinal spasm-like pain","volume":"49","author":"Ge","year":"2011","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"E1612","DOI":"10.1503\/cmaj.201055","article-title":"Hyoscine butylbromide versus acetaminophen for nonspecific colicky abdominal pain in children: A randomized controlled trial","volume":"192","author":"Poonai","year":"2020","journal-title":"CMAJ"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Alammar, N., Wang, L., Saberi, B., Nanavati, J., Holtmann, G., Shinohara, R.T., and Mullin, G.E. (2019). The impact of peppermint oil on the irritable bowel syndrome: A meta-analysis of the pooled clinical data. BMC Complement. Altern. Med., 19.","DOI":"10.1186\/s12906-018-2409-0"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/cts.13129","article-title":"How can real-world evidence aid decision making during the life cycle of non-prescription medicines?","volume":"15","author":"Csoke","year":"2022","journal-title":"Clin. Transl. Sci."},{"key":"ref_27","first-page":"49","article-title":"Acetylsalicylic acid in self-medication of migraine. A pharmacy-based observational study","volume":"21","author":"Gessner","year":"2007","journal-title":"Schmerz"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/EFTV1270","article-title":"Systematic voiding programme in adults with urinary incontinence following acute stroke: The ICONS-II RCT","volume":"26","author":"Watkins","year":"2022","journal-title":"Health Technol. Assess."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0165-6147(94)90047-7","article-title":"Muscarinic acetylcholine receptor subtypes in smooth muscle","volume":"15","author":"Eglen","year":"1994","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e008375","DOI":"10.1136\/bmjopen-2015-008375","article-title":"Systemic exposure to menthol following administration of peppermint oil to paediatric patients","volume":"5","author":"Kearns","year":"2015","journal-title":"BMJ Open"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/21\/6361\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:04:34Z","timestamp":1760144674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/21\/6361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,28]]},"references-count":30,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["jcm11216361"],"URL":"https:\/\/doi.org\/10.3390\/jcm11216361","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints202209.0346.v1","asserted-by":"object"}]},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,28]]}}}